A bipartisan group of lawmakers is pushing Health and Human Services Secretary Robert F. Kennedy Jr. to tighten federal oversight of physician-assisted suicide practices inside hospice and home health care programs, warning that current gaps leave vulnerable patients exposed to abuse with little accountability.
The effort, led by Sen. Marco Rubio and Rep. Brad Wenstrup, centers on a letter sent to Kennedy that calls for HHS to investigate how assisted-suicide drugs are being administered in settings that receive federal funding, as Just the News first reported. The lawmakers argue that the federal government has failed to track or regulate the intersection of hospice care and assisted suicide in states where the practice is legal.
Rubio and Wenstrup, joined by several co-signers, want Kennedy to use his authority at HHS to examine whether Medicare-funded hospice providers are facilitating assisted suicide without adequate safeguards. Their letter raises pointed questions about whether patients in these programs are receiving proper informed consent and whether federal dollars are subsidizing practices that Congress never authorized.
The lawmakers specifically flagged concerns about the growing number of states that have legalized some form of physician-assisted suicide. Ten states and the District of Columbia now permit the practice under varying conditions. But the letter argues that federal oversight has not kept pace with this expansion, particularly inside hospice programs where patients are, by definition, in the final stages of life and often unable to advocate for themselves.
Wenstrup, a physician and Army veteran who served as a combat surgeon in Iraq, brought a clinical perspective to the request. He stressed that the medical profession's duty to "do no harm" requires clear lines between palliative comfort care and active measures to hasten death.
At the core of the lawmakers' concern is a structural problem: hospice care in the United States operates largely on a trust-based model. Medicare's hospice benefit, which covers the vast majority of hospice patients, pays providers a per-diem rate to manage end-of-life comfort. But the program was never designed to account for assisted-suicide protocols, and CMS has not issued clear guidance on how the two interact.
That lack of clarity creates real risks. Hospice patients are among the most medically fragile people in the country. Many suffer from cognitive decline, pain, or emotional distress that can cloud decision-making. The lawmakers warned that without stronger federal guardrails, the potential for coercion or premature death grows as more states open the door to assisted suicide.
The concern is not hypothetical. Federal health care programs have repeatedly shown themselves vulnerable to fraud and abuse at the provider level. A recent DOJ sweep charging 455 defendants in a record $6.5 billion health care fraud operation spanning 41 states exposed just how deeply billing fraud and patient exploitation have penetrated Medicare and Medicaid. Hospice fraud, in particular, has been a growing enforcement target in recent years.
Kennedy has not publicly responded to the letter in detail. But the request lands on his desk at a time when the Trump administration has signaled broad interest in reforming federal health agencies and rooting out waste and abuse across HHS.
Kennedy's confirmation as HHS Secretary was itself contentious, with critics questioning his views on vaccines and public health orthodoxy. But on the issue of patient safety and institutional accountability, the Rubio-Wenstrup letter offers him an opportunity to act on common ground. Protecting dying patients from exploitation is not a partisan question, even if the underlying debate over assisted suicide itself splits along ideological lines.
The broader federal health care enforcement landscape has been active in recent months. The administration has moved aggressively on Medicaid fraud, with Dr. Oz targeting multiple states in an expanding crackdown on fraudulent billing and phantom claims. That same enforcement energy, the lawmakers argue, should extend to hospice programs where life-and-death decisions are being made with minimal federal scrutiny.
Physician-assisted suicide remains one of the most legally fractured issues in American health policy. Federal law does not explicitly ban or authorize the practice. The Supreme Court ruled in 1997, in Washington v. Glucksberg, that there is no constitutional right to assisted suicide, but left the door open for states to legalize it through their own legislatures.
Since then, the patchwork has grown. Oregon was first in 1997. California, Colorado, Hawaii, Maine, Montana, New Jersey, New Mexico, Oregon, Vermont, Washington, and D.C. have all followed with varying statutory frameworks. Some require multiple physician sign-offs. Others impose waiting periods. But none of these state laws address what happens when a patient receiving Medicare-funded hospice care in that state requests lethal medication.
That gap is what Rubio and Wenstrup want Kennedy to close, or at least examine. They are not asking HHS to override state law. Instead, they want the department to clarify whether federal funds can be used in connection with assisted-suicide protocols, whether hospice providers must disclose their policies on the practice, and whether CMS should impose new conditions of participation for hospice programs operating in states where assisted suicide is legal.
The stakes extend beyond policy. Investigators looking into how stolen medical identities fuel deadly fraud have documented cases where vulnerable patients' records were exploited for billing purposes without their knowledge. In hospice settings, where patients are often isolated and declining, the potential for similar exploitation takes on a darker dimension.
The letter drew support from lawmakers who have long pushed for stronger protections for elderly and disabled patients. Several co-signers emphasized that the issue is not simply about the morality of assisted suicide but about the practical mechanics of oversight.
Rubio framed the request as a matter of basic government competence. If federal dollars are flowing into hospice programs, he argued, the federal government has an obligation to know what those programs are doing with that money and to ensure patients are not being steered toward death by providers with financial incentives to shorten costly care.
That financial incentive concern is not trivial. Hospice providers receive a fixed daily rate from Medicare regardless of the services they deliver. A patient who dies sooner costs less. Critics of the current system have long warned that this payment structure creates perverse incentives, and the addition of legal assisted suicide into that mix only sharpens the concern.
The letter asks Kennedy to respond with specific information about current HHS policies, any existing data on assisted-suicide practices within federally funded hospice programs, and a timeline for potential regulatory action. Investigators will need to determine whether CMS has ever audited hospice providers for compliance with state assisted-suicide laws or tracked how often hospice patients in legalization states request or receive lethal prescriptions.
Authorities have not publicly confirmed whether HHS has any internal data on these questions. That silence itself is part of the problem, the lawmakers suggested. If the federal government does not even know the scope of the issue, it cannot protect patients from abuse.
The request also comes as federal law enforcement has stepped up scrutiny of health care providers more broadly. A recent case involving a Chicago clinic owner charged in a multimillion-dollar Medicaid fraud scheme illustrated how brazen provider-level fraud can become when oversight is thin. Hospice care, with its lower-profile patient population and trust-based model, may be even more susceptible.
The assisted-suicide debate has simmered for decades without resolution at the federal level. Supporters call it a compassionate option for the terminally ill. Opponents call it a violation of medical ethics and a slippery slope toward normalized killing of the vulnerable. Both sides have passionate advocates, and neither has won a decisive legal or legislative victory nationwide.
What the Rubio-Wenstrup letter highlights is a narrower but urgent question that cuts across the broader debate: regardless of where one stands on assisted suicide as a moral matter, should the federal government be funding programs that facilitate it without any specific oversight framework? The lawmakers believe the answer is no.
Kennedy now has the letter. Whether he acts on it will say a great deal about how this administration intends to handle the intersection of federal health spending, state-level end-of-life laws, and the rights of patients who cannot fight for themselves.
When the government writes the checks for a dying person's care, it owns a duty to make sure that care does not become a shortcut to the grave.
